1-2 of 2
Stephen Noga, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Uncovering the Blind Spot of Clinical Trials: First Report of Baseline Characteristics of Newly Diagnosed (ND) and Relapsed/Refractory (RR) Multiple Myeloma (MM) Patients (Pts) in Insight-MM, a Global, Prospective, Observational Study

Evangelos Terpos, MD PhD, Ajai Chari, MD, Robert M Rifkin, MD, Rafat Abonour, MD, Jesus G. Berdeja, MD, Mario Boccadoro, Gordon Cook, MD PhD, Caitlin Costello, MD, Saulius Girnius, MD, Hartmut Goldschmidt, MD, Roman Hájek, MD, Vania T M Hungria, MD PhD, Hans C. Lee, MD, Xavier Leleu, MD PhD, Jim Omel, MD, Andrew Spencer, MD, Michael A Thompson, MD, Saad Z Usmani, MD, Jorge Vela-Ojeda, MD PhD, Jeffrey A Zonder, MD, Liviu Niculescu, MD, Stephen Noga, MD, Tomas Skacel, MD, Roxanne Cacioppo, Brittany Sickler, BA, BS, Shawn Yu, Kaili Ren, PhD, Katarina Luptakova, MD, Dawn Marie Stull, Faith E. Davies, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5419.
https://doi.org/10.1182/blood.V130.Suppl_1.5419.5419
Published: 2017
Journal Articles

Costs Associated with Productivity Loss Among U.S. Patients Newly Diagnosed with Multiple Myeloma Receiving Oral Versus Injectable Chemotherapy

David Merola, Candice Yong, Stephen Noga, MD, Kenneth M Shermock, PhD PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3423.
https://doi.org/10.1182/blood.V130.Suppl_1.3423.3423
Published: 2017